Author:
Ellis Darcy E.,Hubbard Rebecca A.,Willis Allison W.,Zuppa Athena F.,Zaoutis Theoklis E.,Hennessy Sean
Funder
Foundation for the National Institutes of Health
National Institute of Neurological Disorders and Stroke
National Institutes of Health
University of Pennsylvania
Subject
Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference27 articles.
1. Opportunities to improve fluoroquinolone prescribing in the United States for adult ambulatory care visits;Kabbani;Clin Infect Dis,2018
2. US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011;Hicks;Clin Infect Dis,2015
3. U.S. outpatient antibiotic prescribing, 2010;Hicks;N Engl J Med,2013
4. Fluoroquinolone prescribing in the United States: 1995 to 2002;Linder;Am J Med,2005
5. Determination That TEQUIN (Gatifloxacin) Was Withdrawn From Sale for Reasons of Safety or Effectiveness U.S.F.a.D. Administration, Editor; 2008. p. 52357–58.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献